We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Removing the DNA Bottleneck in Antibody Discovery

Removing the DNA Bottleneck in Antibody Discovery content piece image

The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them to take more shots on goal, as well as line up these shots effectively. Advances in DNA synthesis technology provide precise antibody variant libraries containing an accurate representation of the designed sequence.

Download this article to learn more about:

  • The value of DNA synthesis in antibody development
  • Developing VHH antibodies from DNA synthesis to animal models
  • The future of antibody discovery